A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease

NCT01491022 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Ampyra first, then Placebo
DRUG: placebo first, then Ampyra

Sponsor

University of Miami

Collaborators

[object Object]